Toussaint Andre Leclercq, MD in Lincoln, RI - Medicare Neurological Surgery

Toussaint Andre Leclercq, MD is a medicare enrolled "Neurological Surgery" physician in Lincoln, Rhode Island. His current practice location is 124 Grandview Ave, Lincoln, Rhode Island. You can reach out to his office (for appointments etc.) via phone at (401) 724-9222.

Toussaint Andre Leclercq is licensed to practice in Rhode Island (license number 04671) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1124002019.

Contact Information

	Toussaint Andre Leclercq, MD
	124 Grandview Ave, Lincoln, RI 02865-2905
	(401) 724-9222
	Not Available

Physician's Profile

Full Name	Toussaint Andre Leclercq
Gender	Male
Speciality	Neurological Surgery
Location	124 Grandview Ave, Lincoln, Rhode Island
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1124002019
Provider Enumeration Date: 12/03/2005
Last Update Date: 04/29/2016

Medicare PECOS Information:

PECOS PAC ID: 6709971526
Enrollment ID: I20170203001207

Medical Identifiers

Medical identifiers for Toussaint Andre Leclercq such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124002019	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207T00000X	Neurological Surgery	04671 (Rhode Island)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Toussaint Andre Leclercq is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Toussaint Andre Leclercq, MD 124 Grandview Ave, Lincoln, RI 02865-2905 Ph: (401) 724-9222	Toussaint Andre Leclercq, MD 124 Grandview Ave, Lincoln, RI 02865-2905 Ph: (401) 724-9222

News Archive

Engineers develop algorithm to monitor joints of patients with arthritis

An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the University of Cambridge.

Axelar AB to present data from ongoing Phase I/II clinical trial of AXL1717

Axelar AB today announced that promising data from the ongoing Phase I/II clinical trial concerning their lead anticancer product AXL1717, an insulin-like growth factor-1 (IGF-1) receptor inhibitor, will be presented next week at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, Massachusetts, USA.

Alzheimer's could be detected early using a blood test

Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

Hemispherx Biopharma, Inc., announced that the Company executed an exclusive revenue sharing Sales, Marketing, Distribution and Supply Agreement for Argentina with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA.

Link between use of anti-TNF therapy and malignant melanoma in RA patients

According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.

Toussaint Andre Leclercq, MD - Medicare Neurological Surgery in Lincoln, RI